sarcoidosis: is there a role for anti-tnf-α?
Clicks: 149
ID: 170972
2007
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
149 views
19 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #80 of 210 articles by views in the journal of applied psychology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 210 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
In severe cases of sarcoidosis treatment can be very difficult. The common treatment strategies might be failing. Tumour necrosis factor (TNF) α therapy is approved in rheumatoid arthritis, M. Crohn, psoriasis and ankylosing spondylitis. In sarcoidosis more recently a phase 2, multicenter, randomized, double-blind, placebo-controlled study was conducted in 138 patients with chronic sarcoidosis with pulmonary involvement. Patients in the combined infliximab groups (3 and 5 mg/kg) had a statistically significant improvement of the FVC (mean increase of 2.5% from baseline to week 24 in the percent of predicted FVC, compared with no change in placebo-treated patients (p=0.038)). Studies in the earlier mentioned diseases revealed that inadequate treatment responses could result from incomplete suppression of TNF α activity. This suggests that increasing patientsâ dose or frequency of infliximab could in turn improve their clinical response. Further evaluation of anti-TNF therapy in symptomatic patients with severe, chronic sarcoidosis is needed. Key-words: Sarcoidosis, tumour necrosis factor, TNF-α, infliximab
| Reference Key |
drent2007revistasarcoidosis:
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Marjolein Drent |
| Journal | the journal of applied psychology |
| Year | 2007 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.